Interpace Pharma Solutions - Ownership and Business Overview

Life ScienceCompany

Interpace Pharma Solutions Ownership

Who owns Interpace Pharma Solutions?

Interpace Pharma Solutions is owned by Flagship Biosciences. It was acquired on August 31, 2022.

Interpace Pharma Solutions Business Overview

Where is Interpace Pharma Solutions headquartered?

Interpace Pharma Solutions is headquartered in Research Triangle Park, North Carolina.

What sector is Interpace Pharma Solutions in?

Interpace Pharma Solutions is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.

Interpace Pharma Solutions

Interpace Pharma Solutions, Inc.

Research Triangle Park, North Carolina
United States,

Interpace Pharma Solutions provides complex molecular analysis services supporting clinical trials and diagnostic development. These services include genomic profiling, biomarker solutions, project and data management, bioinformatics analysis, and biorepository services. Interpace Pharma Solutions is based in Research Triangle Park, North Carolina.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.